Levels of phosphodiesterase 4A and 4B are altered by chronic treatment with psychotropic medications in rat frontal cortex

Synapse

Volumn 64, Issue 7, 2010, Pages 550-555

  Fatemi, S Hossein ^a   Folsom, Timothy D ^a   Reutiman, Teri J ^a   Braun, Natalie N ^a   Lavergne, Luke G ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Frontal cortex; Phosphodiesterase 4A; Phosphodiesterase 4B; Rat; Schizophrenia

Indexed keywords

CLOZAPINE; FLUOXETINE; HALOPERIDOL; LITHIUM; MESSENGER RNA; OLANZAPINE; PHOSPHODIESTERASE; PHOSPHODIESTERASE I; PHOSPHODIESTERASE IA; PHOSPHODIESTERASE IV; PHOSPHODIESTERASE IVA; PHOSPHODIESTERASE IVB; PHOSPHODIESTERASE VIIIB; PSYCHOTROPIC AGENT; SODIUM CHLORIDE; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; GENE EXPRESSION; LONG TERM CARE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; UPREGULATION; WESTERN BLOTTING;

3',5'-CYCLIC-AMP PHOSPHODIESTERASES; ANIMALS; BLOTTING, WESTERN; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 1; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FRONTAL LOBE; MALE; PHOSPHORIC DIESTER HYDROLASES; PSYCHOTROPIC DRUGS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TIME FACTORS;

EID: 77953840852     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20762     Document Type: Article

References (30)

1. Bianchi M, Rossoni G, Sacerdote P, Panerai AE, Berti F. 1995. Effects of chlomipramine and fluoxetine on subcutaneous carrageenin-induced inflammation in the rat. Inflamm Res 44:466-469.
2. Braun NN, Reutiman TJ, Lee S, Folsom TD, Fatemi SH. 2007. Expression of Phosphodiesterase 4 is altered in brain of subjects with autism. NeuroReport 18:1841-1844.
3. Cabanero M, Laje G, Detera-Wadleigh S, McMahon FJ. 2009. Association study of phosphodiesterase genes in the Sequenced Treatment Alternatives to Relieve Depression sample. Pharmacogenet Genomics 19:235-238.
4. D'sa C, Eisch AJ, Bolger GB, Duman RS. 2005. Differential expression and regulation of the cAMP-selective phosphodiesterase type 4A splice variants in rat brain by chronic antidepressant administration. Eur J Neurosci 22:1463-1475.
5. Dlaboga D, Hajjhussein H, O'Donnell JM. 2006. Regulation of phosphodiesterase-4 (PDE4) expression in mouse brain by repeated antidepressant treatment: Comparison with rolipram. Brain Res 1096:104-112.
6. Dlaboga D, Hajjhussein H, O'Donnell JM. 2008. Chronic haloperidol and clozapine produce different patterns of effects on phosphodiesterase-1B, -4B, and -10A expression in rat striatum. Neuropharmacology 54:745-754.
7. Fatemi SH, Snow AV, Stary JM, Araghi-Niknam M, Reutiman TJ, Lee S, Brooks AI, Pearce DA. 2005. Reelin signaling is impaired in autism. Biol Psychiatry 57:777-787.
8. Fatemi SH, Reutiman TJ, Folsom TD, Bell C, Nos L, Fried P, Pearce DA, Singh S, Siderovski DP, Willard FS, Fukuda M. 2006. Chronic olanzapine treatment causes differential expression of genes in frontal cortex of rats as revealed by DNA microarray technique. Neuropsychopharmacology 31:1888-1899.
9. Fatemi SH, King DP, Reutiman TJ, Folsom TD, Laurence JA, Lee S, Fan Y-T, Paciga SA, Conti M, Menniti FS. 2008a. PDE4B polymorphisms and decreased PDE4B expression are associated with schizophrenia. Schizophr Res 101:36-49.
10. Fatemi SH, Reutiman TJ, Folsom TD, Lee S. 2008b. Phosphodiesterase-4A expression is reduced in cerebella of patients with bipolar disorder. Psychiatr Genet 18:282-288.
11. Fatemi SH, Reutiman TJ, Folsom TD. 2009. Chronic psychotropic drug treatment causes differential expression of Reelin signaling system in frontal cortex of rats. Schizophr Res 111:138-152.
12. Gallagher HC, Bacon CL, Odumeru OA, Gallagher KF, Fitzpatrick T, Regan CM. 2004. Valproate activates phosphodiesterase-mediated cAMP degradation: Relevance to C6 glioma G1 phase progression. Neurotoxicol Teratol 26:73-81.
13. Gao XM, Hashimoto T, Cooper TB, Tamminga CA. 1997. The doseresponse characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration. J Neural Transm 104:97-104.
14. Giraldez AJ, Cinalli RM, Glasner ME, Enright AJ, Thomson JM, Baskerville S, Hammond SM, Bartel DP, Schier AF. 2005. Micro-RNAs regulate brain morphogenesis in zebrafish. Science 308:833-838.
15. Houslay MD, Schafer P, Zhang KY. 2005. Keynote review: Phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10:1503-1519.
16. Krichevsky AM, King KS, Donahue CP, Khrapko K, Kosik KS. 2003. A microRNA array reveals extensive regulation of micro-RNAs during brain development. RNA 9:1274-1281.
17. Luo HR, Wu GS, Dong C, Arcos-Burgos M, Ribeiro L, Licinio J, Wong ML. 2009. Association of PDE11A global haplotype with major depression and antidepressant drug response. Neuropsychiatr Dis Treat 5:163-170.
18. Millar JK, Pickard BS, Mackie S, James R, Christie S, Buchanan SR, Malloy MP, Chubb JE, Huston E, Baillie GS, Thomson PA, Hill EV, Brandon NJ, Rain JC, Camargo LM, Whiting PJ, Houslay MD, Blackwood DH, Muir WJ, Porteous DJ. 2005. DISC1 and PDE4B are interacting genetic factors in schizophrenia that regulate cAMP signaling. Science 310:1187-1191.
19. Miro X, Perez-Torres S, Artigas F, Puigdomenech P, Palacios JM, Mengod G. 2002. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43:1148-1157.
20. Nejadkey F, Nahavandi A, Dehpour AR, Mani AR. 2006. Role of nitric oxide in the gastro-protective effect of lithium. Pathophysiology 13:85-89.
21. Pérez-Torres S, Cortés R, Tolnay M, Probst A, Palacios JM, Mengod G. 2003. Alterations on phosphodiesterase type 7 and 8 isozyme mRNA expression in Alzheimer's disease brains examined by in situ hybridization. Exp Neurol 182:322-334.
22. Pickard BS, Thomson PA, Christoforou A, Evans KL, Morris SW, Porteous DJ, Blackwood DH, Muir WJ. 2007. The PDE4B gene confers sex-specific protection against schizophrenia. Psychiatr Genet 17:129-133.
23. Ren M, Leng Y, Jeong MR, Leeds PR, Chuang DM. 2004. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction. J Neurochem 89:1358-1367. (Pubitemid 38802657)
24. Roberts RC. 2001. Effect of chronic olanzapine treatment on striatal synaptic organization. Synapse 39:8-15.
25. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, Kiebler M, Greenberg ME. 2006. A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289. (Pubitemid 43128846)
26. Siuciak JA. 2008. The role of phosphodiesterases in schizophrenia: Therapeutic implications. CNS Drugs 22:983-993.
27. Takahashi M, Terwilliger R, Lane C, Mezes PS, Conti M, Duman RS. 1999. Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms. J Neurosci 19:610-618. (Pubitemid 29036012)
28. Vo N, Klein ME, Varlamova O, Keller DM, Yamamoto T, Goodman RH, Impey S. 2005. A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis. Proc Natl Acad Sci USA 102:16426-16431.
29. Wong ML, Whelan F, Deloukas P, Whittaker P, Delgado M, Cantor RM, McCann SM, Licinio J. 2006. Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response. Proc Natl Acad Sci USA 103:15124-15129.
30. Ye Y, Jackson K, O'Donnell JM. 2000. Effects of repeated antidepressant treatment of type 4A phosphodiesterase (PDE4A) in rat brain. J Neurochem 74:1257-1262. (Pubitemid 30104324)